The impact of lipid-lowering medications on coronary artery plaque characteristics
Atherosclerosis is the predominant cause of coronary artery disease. The last several decades have witnessed significant advances in lipid-lowering therapies, which comprise a central component of atherosclerotic cardiovascular disease prevention. In addition to cardiovascular risk reduction with dy...
Guardado en:
Autores principales: | Vishnu Priya Pulipati, Francis J. Alenghat |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7f0b4c91947a49e98adcdcd27ed300e5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Long-Term Abnormalities of Lipid Profile After a Single Episode of Sepsis
por: Nicholas Felici, et al.
Publicado: (2021) -
Prevalence of Healed Plaque and Factors Influencing Its Characteristics Under Optical Coherence Tomography in Patients With Coronary Artery Disease: A Systematic Review, Meta-Analysis, and Meta-Regression
por: Xunxun Feng, et al.
Publicado: (2021) -
Optical Coherence Tomography-Derived Changes in Plaque Structural Stress Over the Cardiac Cycle: A New Method for Plaque Biomechanical Assessment
por: Jiayue Huang, et al.
Publicado: (2021) -
Prevalence of Carotid Plaque in a 63‐ to 65‐Year‐Old Norwegian Cohort From the General Population: The <styled-content style="fixed-case">ACE</styled-content> (Akershus Cardiac Examination) 1950 Study
por: Håkon Ihle‐Hansen, et al.
Publicado: (2018) -
Association between abdominal aortic plaque and coronary artery disease
por: Li W, et al.
Publicado: (2016)